Catalyx, an Irish-based machine vision and automation company with a facility in Newtown, recently partnered with Slovenia-based INEL, an advanced machine builder, to deliver innovative, end-to-end packaging solutions.
The partnership will allow the companies to improve inspection, verification, serialization, and labeling processes, as well as streamline high-volume manufacturing tools. Streamlining will allow the companies to ensure pharmaceutical production meets stringent standards while driving industry innovation.
“This partnership with INEL allows us to elevate our offerings in the life sciences sector,” Stefaan Vanassche, chief commercial officer at Catalyx, said. “By merging INEL’s expertise in automation with our industry-leading service capabilities, we are poised to deliver solutions that improve efficiency, ensure regulatory compliance, and support the evolving needs of global pharmaceutical manufacturers.”
Catalyx specializes in life sciences and other highly regulated industries. Founded in 2022 with the merger of CXV Global and Panacea Technologies, the company’s technologies allow customers to achieve maximum efficiency, quality, compliance, and profitability. It operates throughout North America and Europe.
INEL serves the pharmaceutical, medical device, cosmetics, and food and beverage industries, specializing in serialization, aggregation, labeling, packaging, and end-of-line solutions. It provides printing, labeling, inspection, and serialization systems.
The company has formed partnerships in Europe, Australia, and the Americas.